查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1826799

2025年介入性神經放射學全球市場報告

Interventional Neuroradiology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，介入性神經放射學市場規模強勁成長，從2024年的19.4億美元增加至2025年的20.5億美元，複合年成長率為5.9%。預測期內的成長可歸因於導管介入治療的廣泛接受、醫療基礎設施的不斷擴展、高血壓盛行率的上升、糖尿病盛行率的上升以及遠端醫療的擴展。

介入性神經放射學市場預計將在未來幾年強勁成長，到2029年將達到25.9億美元，複合年成長率為5.9%。預測期內的成長歸因於液體栓塞劑的引入、血管內治療方法的普及、機械性切除術的普及、對可拆卸栓塞線圈的依賴性不斷增強以及生物可吸收支架的廣泛應用。預測期內的主要趨勢包括導航系統的進步、滲透性支援設備的創新、人工智慧在神經影像設備中的整合、血栓除去裝置的最佳化以及介入設備中的人工智慧干預。

介入性神經放射學 (INR) 是一門專注於使用微創技術診斷和治療影響大腦、脊椎和血管的神經系統疾病的醫學專業。此方法使用先進的影像技術來指導導管介入、血管成形術、置入術和栓塞術等手術。

介入性神經放射學的主要器械包括微導管、神經血管栓塞和栓塞輔助裝置、栓塞線圈、血流轉向裝置、液體栓塞劑、附件和導管導引線。微導管是一種細而柔韌的管狀器械，用於進入腦部和脊椎複雜的細小血管。這些器械用於治療腦動脈瘤、顱內腫瘤和急性中風，並應用於各種環境，包括醫院、門診手術中心和診斷中心。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療保健產業產生了重大影響，尤其是基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正努力應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本，其中許多產品的國內替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力，一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外，原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產，導致供應鏈延遲。作為應對措施，該行業正在採用多樣化的籌資策略，盡可能擴大本地生產，並遊說對關鍵醫療產品免關稅。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供介入神經放射學市場統計數據，例如介入神經放射學行業的全球市場規模、各地區市場佔有率、介入神經放射學市場佔有率的競爭對手、介入神經放射學細分市場的詳細情況、市場趨勢和商機，以及您在介入神經放射學行業取得成功所需的數據。本介入性神經放射學市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

未來五年5.9%的成長率預測比我們先前的預測略有下降，下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將阻礙美國，包括增加來自法國和愛爾蘭的神經血管支架和血流改道裝置的成本、推遲卒中干涉措施以及增加介入神經放射學實驗室的成本。由於互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響，其影響也將更加廣泛。

神經系統疾病盛行率的不斷上升預計將推動介入神經放射學市場的成長。這些影響大腦、脊髓和周邊神經的疾病會損害運動、感覺、認知和溝通。神經系統疾病的增加主要是由於全球人口老化，這增加了阿茲海默症與老齡化相關的疾病的風險。診斷技術的進步也使得更早、更準確地發現這些疾病成為可能。介入性神經放射學使用微創、影像導引技術來診斷和治療動脈瘤、中風和動靜脈畸形等疾病。例如，英國阿茲海默症研究中心在 2023 年 5 月報告稱，失智症是 2022 年英國的主要死因，死亡人數超過 74,000 人，比前一年增加了 5,000 人。因此，神經系統疾病的增加正在推動介入神經放射學市場的成長。

介入性神經放射學市場的主要參與者正致力於開發先進的解決方案，例如頭部固定裝置，以改善神經放射學和介入放射學手術中的影像品質和病人安全。頭部固定裝置是用於暫時固定患者頭部和頸部的醫療設備，主要用於在疑似頭部或脊椎損傷的情況下確保安全和穩定。例如，2023年6月，紐西蘭製造商Adept Medical推出了一款新型頭部固定裝置，以提高患者在手術過程中的舒適度和影像品質。該裝置採用真空吸力技術，可牢固地固定頭部；其滲透性的設計可最大限度地減少對X光成像的干擾；並且兼容各種成像台。它還透過快速設定提高了工作流程效率，並適應各種頭型，確保患者的舒適度。

2023年1月，美國醫療保健公司GE醫療科技收購了法國醫療技術公司IMACTIS，後者專注於導航系統用電腦斷層掃描技術。收購條款尚未披露。 GE醫療希望透過此次收購，整合CT導航技術，改善介入引導的傳遞，提高手術準確性，減少差異性，並擴展其在介入放射學領域的能力。此次收購也旨在將IMACTIS的解決方案拓展到各個醫療領域。

介入性神經放射學市場由提供栓塞術、球囊血管成形術、血管內卷取和機械血栓切除術等服務的營業單位所獲得的收益所構成。市場價值包括服務提供者銷售或包含在其服務產品中的相關商品的價值。介入性神經放射學市場還包括栓塞劑、導管導引線、顯微手術器械和神經血管導管的銷售。該市場中的商品價值為“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球介入性神經放射學：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球介入性神經放射學市場：成長率分析
  • 全球介入性神經放射學市場表現：規模與成長，2019-2024
  • 全球介入性神經放射學市場預測：2024-2029年及2034年規模與成長
  • 全球介入神經放射學：總目標市場（TAM）

第6章 市場細分

  • 全球介入性神經放射學市場（按設備類型）：實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 微導管
  • 神經血管栓塞及線圈栓塞輔助裝置
  • 栓塞線圈
  • 導流裝置
  • 液態栓塞劑
  • 配件
  • 導管導引線
  • 全球介入性神經放射學市場：依疾病、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 腦動脈瘤
  • 顱內腫瘤
  • 急性中風
  • 其他疾病
  • 全球介入性神經放射學市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 診斷中心
  • 全球介入性神經放射學市場：按微導管類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 單腔微導管
  • 雙腔微導管
  • 高流量微導管
  • 全球介入性神經放射學市場：神經血管栓塞和線圈栓塞輔助裝置的細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 線圈輔助裝置
  • 栓塞輔助裝置
  • 全球介入性神經放射學市場：栓塞線圈細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 軟線圈
  • 硬線圈
  • 可拆卸線圈
  • 全球介入性神經放射學市場：按流量分流裝置細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 基於支架的血流改道裝置
  • 無支架血流改道裝置
  • 全球介入性神經放射學市場：液體栓塞劑細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 聚合物基液態栓塞劑
  • 凝膠基液態栓塞劑
  • Onyx液體栓塞劑
  • 全球介入性神經放射學市場：依配件（按類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 引導管
  • 鞘套導引器
  • 靜脈通路裝置
  • 全球介入性神經放射學市場：按導管導引線類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 親水性導管導引線
  • 可推導管導引線
  • 塗層導管導引線

第7章 區域和國家分析

  • 全球介入性神經放射學市場：區域分析、預測與成長，2019-2024 年、2024-2029 年、2034 年
  • 全球介入性神經放射學市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 介入性神經放射學市場：競爭格局
  • 介入性神經放射學市場：公司簡介
    • Bayer HealthCare Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Philips Healthcare
  • Stryker Corporation
  • GE Healthcare Life Sciences
  • Boston Scientific Corporation
  • Terumo Corporation
  • Canon Medical Systems Corporation
  • WL Gore & Associates Inc.
  • Teleflex Incorporated
  • Cook Medical LLC
  • Biotronik SE & Co. KG
  • Merit Medical Systems Inc.
  • MicroPort Scientific Corporation
  • Penumbra Inc.
  • Guerbet Group
  • Mediterra LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年介入性神經放射學市場：提供新機會的國家
  • 2029年介入性神經放射學市場：細分領域帶來新機會
  • 2029年介入性神經放射學市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r33783u

Interventional neuroradiology (INR) is a specialized medical field that focuses on the use of minimally invasive techniques to diagnose and treat neurological conditions affecting the brain, spine, and blood vessels. This approach employs advanced imaging methods to guide procedures such as catheter-based treatments, angioplasties, stent placements, and embolization.

The primary devices used in interventional neuroradiology include microcatheters, neurovascular embolization and coiling assist devices, embolic coils, flow diversion devices, liquid embolic agents, accessories, and micro guidewires. Microcatheters are thin, flexible tubes designed to navigate intricate and small blood vessels in the brain and spine during procedures. These devices are utilized in treating conditions such as cerebral aneurysms, intracranial tumors, acute strokes, and others, with applications across various settings such as hospitals, ambulatory surgical centers, and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The interventional neuroradiology market research report is one of a series of new reports from The Business Research Company that provides interventional neuroradiology market statistics, including interventional neuroradiology industry global market size, regional shares, competitors with an interventional neuroradiology market share, detailed interventional neuroradiology market segments, market trends and opportunities, and any further data you may need to thrive in the interventional neuroradiology industry. This interventional neuroradiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The interventional neuroradiology market size has grown strongly in recent years. It will grow from $1.94 billion in 2024 to $2.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to wider acceptance of catheter-based intervention, expanding healthcare infrastructure, rising prevalence of hypertension, rising prevalence of diabetes, and expansion of telemedicine.

The interventional neuroradiology market size is expected to see strong growth in the next few years. It will grow to $2.59 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to introduction of liquid embolic agent, adoption of endovascular treatment methods, rise in use of mechanical throbectomy, growing reliance on detachable embolic coils, and increasing deployment of bioresobable scaffolds. Major trends in the forecast period include advancements in navigation systems, innovations in radiolucent support devices, integration of artificial intelligence in neuroimaging devices, optimization of thrombectomy devices, and intervention of artificial intelligence in intervention devices.

The forecast of 5.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of neurovascular stents and flow diversion devices sourced from France and Ireland, thereby delaying stroke interventions and elevating neurointerventional lab costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of neurological disorders is anticipated to drive the growth of the interventional neuroradiology market. These disorders, which affect the brain, spinal cord, or peripheral nerves, can impair movement, sensation, cognition, or communication. The rise in neurological conditions is largely attributed to the aging global population, which heightens the risk of age-related diseases such as Alzheimer's. Additionally, advancements in diagnostic technologies enable earlier and more precise detection of these disorders. Interventional neuroradiology uses minimally invasive, image-guided methods to diagnose and treat conditions such as aneurysms, strokes, and arteriovenous malformations. For example, Alzheimer's Research UK reported in May 2023 that dementia was the leading cause of death in the UK in 2022, with over 74,000 deaths, reflecting a rise of 5,000 from the previous year. As a result, the increasing number of neurological disorders is fueling the growth of the interventional neuroradiology market.

Key players in the interventional neuroradiology market are focusing on developing advanced solutions such as head immobilizers to improve imaging quality and patient safety during neuroradiology and interventional radiology procedures. A head immobilizer is a medical device designed to temporarily immobilize a patient's head and neck, primarily for safety and stability when a head or spinal injury is suspected. For instance, in June 2023, Adept Medical, a New Zealand-based manufacturer, introduced a new head immobilizer that enhances patient comfort and imaging quality during these procedures. The device features vacuum suction technology for secure head fixation, a radiolucent design that minimizes interference with X-ray imaging, and compatibility with various imaging tables. Its quick setup process improves workflow efficiency, and its ability to accommodate different head shapes ensures patient comfort.

In January 2023, GE Healthcare Technologies Inc., a US-based healthcare company, acquired IMACTIS, a France-based medical technology company specializing in computed tomography for navigation systems. The terms of the acquisition were not disclosed. With this acquisition, GE Healthcare intends to improve its interventional guidance offerings by integrating CT-Navigation technology, thereby enhancing procedural accuracy, reducing variability, and expanding its capabilities in interventional radiology. This acquisition also aims to scale IMACTIS's solutions across various medical fields.

Major players in the interventional neuroradiology market are Bayer HealthCare, Abbott Laboratories, Medtronic PLC, Siemens Healthineers AG, Fujifilm Corporation, Philips Healthcare, Stryker Corporation, GE Healthcare Life Sciences, Boston Scientific Corporation, Terumo Corporation, Canon Medical Systems Corporation, W. L. Gore & Associates Inc., Teleflex Incorporated, Cook Medical LLC, Biotronik SE & Co. KG, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Guerbet Group, Mediterra LLC, Acandis GmbH, and Medico's Hirata Inc.

North America was the largest region in the interventional neuroradiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional neuroradiology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interventional neuroradiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional neuroradiology market consists of revenues earned by entities by providing services such as embolization procedures, balloon angioplasty, endovascular coiling, and mechanical thrombectomy. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional neuroradiology market also includes sales of embolization agents, guidewires, microsurgical instruments, and neurovascular catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Neuroradiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional neuroradiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional neuroradiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The interventional neuroradiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Device Type: Microcatheters; Neurovascular Embolization And Coiling Assist Devices; Embolic Coils; Flow Diversion Devices; Liquid Embolic Agents; Accessories; Micro Guidewires
  • 2) By Disease: Cerebral Aneurysms; Intra-Cranial Tumors; Acute Strokes; Other Diseases
  • 3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers
  • Subsegments:
  • 1) By Microcatheters: Single-Lumen Microcatheters; Dual-Lumen Microcatheters; High-Flow Microcatheters
  • 2) By Neurovascular Embolization And Coiling Assist Devices: Coiling Assist Devices; Embolization Assist Devices
  • 3) By Embolic Coils: Soft Coils; Stiff Coils; Detachable Coils
  • 4) By Flow Diversion Devices: Stent-Based Flow Diversion Devices; Non-Stent-Based Flow Diversion Devices
  • 5) By Liquid Embolic Agents: Polymer-Based Liquid Embolic Agents; Gel-Based Liquid Embolic Agents; Onyx Liquid Embolic Agents
  • 6) By Accessories: Guide Catheters; Sheath Introducers; Vascular Access Devices
  • 7) By Micro Guidewires: Hydrophilic Micro Guidewires; Pushable Micro Guidewires; Coated Micro Guidewires
  • Companies Mentioned: Bayer HealthCare; Abbott Laboratories; Medtronic PLC; Siemens Healthineers AG; Fujifilm Corporation; Philips Healthcare; Stryker Corporation; GE Healthcare Life Sciences; Boston Scientific Corporation; Terumo Corporation; Canon Medical Systems Corporation; W. L. Gore & Associates Inc.; Teleflex Incorporated; Cook Medical LLC; Biotronik SE & Co. KG; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Penumbra Inc.; Guerbet Group; Mediterra LLC; Acandis GmbH; Medico's Hirata Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Neuroradiology Market Characteristics

3. Interventional Neuroradiology Market Trends And Strategies

4. Interventional Neuroradiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Interventional Neuroradiology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Interventional Neuroradiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Interventional Neuroradiology Market Growth Rate Analysis
  • 5.4. Global Interventional Neuroradiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Interventional Neuroradiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Interventional Neuroradiology Total Addressable Market (TAM)

6. Interventional Neuroradiology Market Segmentation

  • 6.1. Global Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microcatheters
  • Neurovascular Embolization And Coiling Assist Devices
  • Embolic Coils
  • Flow Diversion Devices
  • Liquid Embolic Agents
  • Accessories
  • Micro Guidewires
  • 6.2. Global Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cerebral Aneurysms
  • Intra-Cranial Tumors
  • Acute Strokes
  • Other Diseases
  • 6.3. Global Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • 6.4. Global Interventional Neuroradiology Market, Sub-Segmentation Of Microcatheters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Lumen Microcatheters
  • Dual-Lumen Microcatheters
  • High-Flow Microcatheters
  • 6.5. Global Interventional Neuroradiology Market, Sub-Segmentation Of Neurovascular Embolization And Coiling Assist Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coiling Assist Devices
  • Embolization Assist Devices
  • 6.6. Global Interventional Neuroradiology Market, Sub-Segmentation Of Embolic Coils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Soft Coils
  • Stiff Coils
  • Detachable Coils
  • 6.7. Global Interventional Neuroradiology Market, Sub-Segmentation Of Flow Diversion Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stent-Based Flow Diversion Devices
  • Non-Stent-Based Flow Diversion Devices
  • 6.8. Global Interventional Neuroradiology Market, Sub-Segmentation Of Liquid Embolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymer-Based Liquid Embolic Agents
  • Gel-Based Liquid Embolic Agents
  • Onyx Liquid Embolic Agents
  • 6.9. Global Interventional Neuroradiology Market, Sub-Segmentation Of Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Guide Catheters
  • Sheath Introducers
  • Vascular Access Devices
  • 6.10. Global Interventional Neuroradiology Market, Sub-Segmentation Of Micro Guidewires, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hydrophilic Micro Guidewires
  • Pushable Micro Guidewires
  • Coated Micro Guidewires

7. Interventional Neuroradiology Market Regional And Country Analysis

  • 7.1. Global Interventional Neuroradiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Interventional Neuroradiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Neuroradiology Market

  • 8.1. Asia-Pacific Interventional Neuroradiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Neuroradiology Market

  • 9.1. China Interventional Neuroradiology Market Overview
  • 9.2. China Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Neuroradiology Market

  • 10.1. India Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Neuroradiology Market

  • 11.1. Japan Interventional Neuroradiology Market Overview
  • 11.2. Japan Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Neuroradiology Market

  • 12.1. Australia Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Neuroradiology Market

  • 13.1. Indonesia Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Neuroradiology Market

  • 14.1. South Korea Interventional Neuroradiology Market Overview
  • 14.2. South Korea Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Neuroradiology Market

  • 15.1. Western Europe Interventional Neuroradiology Market Overview
  • 15.2. Western Europe Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Neuroradiology Market

  • 16.1. UK Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Neuroradiology Market

  • 17.1. Germany Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Neuroradiology Market

  • 18.1. France Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Neuroradiology Market

  • 19.1. Italy Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Neuroradiology Market

  • 20.1. Spain Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Neuroradiology Market

  • 21.1. Eastern Europe Interventional Neuroradiology Market Overview
  • 21.2. Eastern Europe Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Neuroradiology Market

  • 22.1. Russia Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Neuroradiology Market

  • 23.1. North America Interventional Neuroradiology Market Overview
  • 23.2. North America Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Neuroradiology Market

  • 24.1. USA Interventional Neuroradiology Market Overview
  • 24.2. USA Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Neuroradiology Market

  • 25.1. Canada Interventional Neuroradiology Market Overview
  • 25.2. Canada Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Neuroradiology Market

  • 26.1. South America Interventional Neuroradiology Market Overview
  • 26.2. South America Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Neuroradiology Market

  • 27.1. Brazil Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Neuroradiology Market

  • 28.1. Middle East Interventional Neuroradiology Market Overview
  • 28.2. Middle East Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Neuroradiology Market

  • 29.1. Africa Interventional Neuroradiology Market Overview
  • 29.2. Africa Interventional Neuroradiology Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Interventional Neuroradiology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Interventional Neuroradiology Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Neuroradiology Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Neuroradiology Market Competitive Landscape
  • 30.2. Interventional Neuroradiology Market Company Profiles
    • 30.2.1. Bayer HealthCare Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Fujifilm Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Neuroradiology Market Other Major And Innovative Companies

  • 31.1. Philips Healthcare
  • 31.2. Stryker Corporation
  • 31.3. GE Healthcare Life Sciences
  • 31.4. Boston Scientific Corporation
  • 31.5. Terumo Corporation
  • 31.6. Canon Medical Systems Corporation
  • 31.7. W. L. Gore & Associates Inc.
  • 31.8. Teleflex Incorporated
  • 31.9. Cook Medical LLC
  • 31.10. Biotronik SE & Co. KG
  • 31.11. Merit Medical Systems Inc.
  • 31.12. MicroPort Scientific Corporation
  • 31.13. Penumbra Inc.
  • 31.14. Guerbet Group
  • 31.15. Mediterra LLC

32. Global Interventional Neuroradiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Neuroradiology Market

34. Recent Developments In The Interventional Neuroradiology Market

35. Interventional Neuroradiology Market High Potential Countries, Segments and Strategies

  • 35.1 Interventional Neuroradiology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Interventional Neuroradiology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Interventional Neuroradiology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer